Agnese Cosenza

Soluble PD-L1 and Circulating CD8+PD-1+ and NK Cells Enclose a Prognostic and Predictive Immune Effector Score in Immunotherapy Treated NSCLC patients

Giulia Mazzaschi, Roberta Minari, Alessandra Zecca et al. · Lung Cancer · 2020 · 114 citations

Cancer Immunosurveillance, Autoimmune Disease, Allergy +11

From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC

Paola Bordi, Marzia Del Re, Roberta Minari et al. · Lung Cancer · 2019 · 52 citations · Full text

Therapeutic Drug Monitoring, Medicine, Advanced T790m-positive Nsclc +6

Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genotyping on tissue and liquid biopsies

Alessandro Leonetti, Michela Verzè, Roberta Minari et al. · British Journal of Cancer · 2023 · 40 citations · Full text

Advanced Egfr-mutated Nsclc, Bone Morphogenic Protein, Medicine +6

PD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors

Roberta Minari, Francesco Bonatti, Giulia Mazzaschi et al. · Tumori Journal · 2021 · 38 citations

Clinical and Hematologic Parameters Address the Outcomes of Non-Small-Cell Lung Cancer Patients Treated With Nivolumab

Francesco Facchinetti, Michele Veneziani, Sebastiano Buti et al. · Immunotherapy · 2018 · 37 citations